Everybody was trying to destroy Cytodyn 08/29/2023
Post# of 148117
https://assets.pcaobus.org/pcaob-dev/docs/def...4ba840f7_2
https://pcaobus.org/news-events/news-releases...violations
On the basis of Respondent’s Offer, the Board finds that:
A. Respondent
1. Warren Averett, LLC is a limited liability company organized under the laws of
the state of Alabama and headquartered in Birmingham, Alabama. Warren Averett is licensed
to practice public accounting by the Alabama State Board of Public Accountancy (Firm
No. F2171), among other state boards. Warren Averett is, and at all relevant times was,
registered with the Board, and is a registered public accounting firm as that term is defined in
Section 2(a)(12) of the Act and PCAOB rules.
B. Issuer
2. CytoDyn Inc. (“CytoDyn”) is a Delaware corporation headquartered in
Vancouver, Washington. According to its public filings, CytoDyn is a clinical-stage biotechnology
company focused on developing medical treatments. At all relevant times, CytoDyn was an
“issuer” as that term is defined by Section 2(a)(7) of the Act and PCAOB Rule 1001(i)(iii).
C. Summary
3. This matter concerns Warren Averett’s violations of auditor independence
requirements during the fiscal year 2019 and 2020 CytoDyn audits.
4. Warren Averett is a member of BDO Alliance USA (the “BDO Alliance”), an
association of accounting firms that is a wholly-owned subsidiary of BDO USA, LLP (“BDO”). As a